EAST MEETS WEST - THE QUEST FOR CURE Trademark

Trademark Overview

On Sunday, July 22, 2018, a trademark application was filed for EAST MEETS WEST - THE QUEST FOR CURE with the United States Patent and Trademark Office. The USPTO has given the EAST MEETS WEST - THE QUEST FOR CURE trademark a serial number of 88047545. The federal status of this trademark filing is REGISTERED as of Tuesday, August 20, 2024. This trademark is owned by Shenzhen HighTide Biopharmaceutical, Ltd.. The EAST MEETS WEST - THE QUEST FOR CURE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services and research and development relating thereto for medical purposes, namely, scientific investigations and product development for medical purposes; scientific research; pharmaceutical research and development
east meets west - the quest for cure

General Information

Serial Number88047545
Word MarkEAST MEETS WEST - THE QUEST FOR CURE
Filing DateSunday, July 22, 2018
Status700 - REGISTERED
Status DateTuesday, August 20, 2024
Registration Number7482386
Registration DateTuesday, August 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Goods and ServicesScientific and technological services and research and development relating thereto for medical purposes, namely, scientific investigations and product development for medical purposes; scientific research; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 26, 2018
Primary Code042
First Use Anywhere DateTuesday, December 31, 2019
First Use In Commerce DateTuesday, December 31, 2019

Trademark Owner History

Party NameShenzhen HighTide Biopharmaceutical, Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressShenzhen, Guangdong 518112
CN
Party NameShenzhen HighTide Biopharmaceutical, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressShenzhen, Guangdong 518112
CN
Party NameShenzhen HighTide Biopharmaceutical, Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShenzhen, Guangdong 518112
CN

Trademark Events

Event DateEvent Description
Wednesday, July 25, 2018NEW APPLICATION ENTERED
Thursday, July 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 8, 2018ASSIGNED TO EXAMINER
Saturday, November 10, 2018NON-FINAL ACTION WRITTEN
Saturday, November 10, 2018NON-FINAL ACTION E-MAILED
Saturday, November 10, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 3, 2019SUSPENSION LETTER WRITTEN
Monday, June 3, 2019LETTER OF SUSPENSION E-MAILED
Monday, June 3, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, December 27, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 15, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 26, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, September 8, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 4, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 1, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 1, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 3, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Friday, July 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Monday, January 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 23, 2023USE AMENDMENT FILED
Tuesday, November 7, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, October 23, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, November 4, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, December 4, 2023NON-FINAL ACTION E-MAILED
Monday, June 17, 2024ASSIGNED TO LIE
Monday, July 15, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, February 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

cure quest west meets east scientific research development medical purposes pharmaceutical investigations namely product thereto